홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Dicyclohexylcarbodiimide → t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-3-O-[(R)-3-benzyloxy-dodecanoyl]-2-deoxy-beta-D-glucopyranoside

HRID 628195
노트
인쇄 미리보기

반응식

HRID 628195 반응식
[CH2:1]([O:8][C@H:9]([CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH3:22])[CH2:10][C:11]([OH:13])=[O:12])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C1CCC(N=C=NC2CCCCC2)CC1.[CH2:38]([O:41][C:42]([O:44][C@H:45]1[C@H:50]([O:51][P:52]2(=[O:63])[O:58][CH2:57][C:56]3[CH:59]=[CH:60][CH:61]=[CH:62][C:55]=3[CH2:54][O:53]2)[C@@H:49]([CH2:64][O:65][CH2:66][C:67]2[CH:72]=[CH:71][CH:70]=[CH:69][CH:68]=2)[O:48][C@@H:47]([O:73][CH2:74][C@H:75]2[O:88][C@@H:79]([O:80][Si:81]([C:84]([CH3:87])([CH3:86])[CH3:85])([CH3:83])[CH3:82])[C@H:78]([N:89]=[N+:90]=[N-:91])[C@@H:77](O)[C@@H:76]2[O:93][CH2:94][C:95]2[CH:100]=[CH:99][CH:98]=[CH:97][CH:96]=2)[C@@H:46]1[NH:101][C:102](=[O:130])[CH2:103][C@H:104]([O:116][C:117](=[O:129])[CH2:118][CH2:119][CH2:120][CH2:121][CH2:122][CH2:123][CH2:124][CH2:125][CH2:126][CH2:127][CH3:128])[CH2:105][CH2:106][CH2:107][CH2:108][CH2:109][CH2:110][CH2:111][CH2:112][CH2:113][CH2:114][CH3:115])=[O:43])[CH:39]=[CH2:40]>C(Cl)Cl.CN(C1C=CN=CC=1)C>[CH2:38]([O:41][C:42]([O:44][C@H:45]1[C@H:50]([O:51][P:52]2(=[O:63])[O:58][CH2:57][C:56]3[CH:59]=[CH:60][CH:61]=[CH:62][C:55]=3[CH2:54][O:53]2)[C@@H:49]([CH2:64][O:65][CH2:66][C:67]2[CH:68]=[CH:69][CH:70]=[CH:71][CH:72]=2)[O:48][C@@H:47]([O:73][CH2:74][C@H:75]2[O:88][C@@H:79]([O:80][Si:81]([C:84]([CH3:85])([CH3:87])[CH3:86])([CH3:82])[CH3:83])[C@H:78]([N:89]=[N+:90]=[N-:91])[C@@H:77]([O:12][C:11](=[O:13])[CH2:10][C@H:9]([O:8][CH2:1][C:2]3[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=3)[CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH3:22])[C@@H:76]2[O:93][CH2:94][C:95]2[CH:96]=[CH:97][CH:98]=[CH:99][CH:100]=2)[C@@H:46]1[NH:101][C:102](=[O:130])[CH2:103][C@H:104]([O:116][C:117](=[O:129])[CH2:118][CH2:119][CH2:120][CH2:121][CH2:122][CH2:123][CH2:124][CH2:125][CH2:126][CH2:127][CH3:128])[CH2:105][CH2:106][CH2:107][CH2:108][CH2:109][CH2:110][CH2:111][CH2:112][CH2:113][CH2:114][CH3:115])=[O:43])[CH:39]=[CH2:40]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 3

HCID 10868DicyclohexylcarbodiimideHCID 16216230t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-2-deoxy-beta-D-glucopyranosideHCID 67004404(r)-3-Benzyloxy-dodecanoic acid

생성물 1

HCID 87233474
t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-3-O-[(R)-3-benzyloxy-dodecanoyl]-2-deoxy-beta-D-glucopyranoside
수율 91%

시약·촉매·용매 2

HCID 142844-(Dimethylamino)pyridine촉매HCID 6344Dichloromethane용매2회

실험 절차

A solution of (R)-3-benzyloxy-dodecanoic acid 14 (86 mg, 0.281 mmol) and DCC (78 mg, 0.376 mmol) in DCM (5 mL) was stirred at room temperature for 10 min, and then disaccharide 21 (250 mg, 0.188 mmol) in DCM (2 mL) and DMAP (11 mg, 0.094 mmol) were added. The reaction mixture was stirred for another 14 h, after which the solids were removed by filtration, and the residue was washed with DCM (2×1 mL). The combined filtrates were concentrated in vacuo, and the residue was purified by silica gel column chromatography (hexane/ethyl acetate, 4/1, v/v) to give 36 as a white solid (277 mg, 91%). Rf=0.41 (hexane/ethyl acetate, 2/1, v/v). [α]26D=−3.0° (c=1.0, CHCl3). 1H NMR (600 MHz, CDCl3): δ 7.34-7.15 (m, 19H, aromatic), 6.01 (d, 1H, JNH′,2=7.2 Hz, NH′), 5.92-6.86 (m, 1H, OCH2CH═CH2), 5.46 (t, 1H, J2′,3′=J3′,4′=9.6 Hz, H-3′), 5.34 (d, 1H, J=16.8 Hz, OCH2CH═CH2), 5.22 (d, 1H, J=10.8 Hz, OCH2CH═CH2), 5.08-4.97 (m, 7H, H-1′, H-3, H-3L, C6H4(CH2O)2P), 4.61-4.45 (m, 10H, H-1, H-4′, 3×CH2Ph, OCH2CH═CH2), 3.97 (d, 1H, J6′a,6′b=10.5 Hz, H-6′a), 3.88-3.86 (m, 1H, H-3S), 3.81 (d, 1H, J6a,6b=9.5 Hz, H-6a), 3.73-3.68 (m, 3H, H-5′, H-6b, H-6′b), 3.56-3.46 (m, 3H, H-2′, H-4, H-5), 3.28 (dd, 1H, J1,2=7.8 Hz, J2,3=10.2 Hz, H-2), 2.56 (dd, 1H, J2Sa,2Sb=15.6 Hz, J2Sa,3S=7.2 Hz, H-2Sa), 2.44 (dd, 1H, J2Sa,2Sb=15.6 Hz, J2Sb,S3=6.0 Hz, H-2Sb), 2.36 (dd, 1H, J2La,2Lb=15.0 Hz, J2La,3 L=6.0 Hz, H-2La), 2.30-2.21 (m, 3H, H-2L′, H-2L′b), 1.57-1.53 (m, 6H, H-4L, H-4S, H-3L′), 1.24 (broad, 48H, 24×CH2, lipid), 0.90 (s, 9H, SiC(CH3)3), 0.89-0.85 (m, 9H, 3×CH3, lipid), 0.13 (s, 6H, Si(CH3)2). 13C NMR (75 MHz, CDCl3): δ 173.54 (C═O), 170.64 (C═O), 170.03 (C═O), 154.49 (C═O), 138.52-127.43 (aromatic, OCH2CH═CH2), 118.84 (OCH2CH═CH2), 99.34 (C-1′), 97.02 (C-1), 76.00, 75.70, 74.33, 74.08, 73.73, 73.48, 71.46, 71.01, 68.95-67.99 (m), 66.55, −4.13 (Si(CH3)2), −5.32 (Si(CH3)2). HR MS (m/z) calculated for C89H135N4O19PSi [M+Na], 1645.9125. found, 1646.2435.

후처리

  1. customafter which the solids were removed by filtration
  2. washthe residue was washed with DCM (2×1 mL)
  3. concentrationThe combined filtrates were concentrated in vacuo
  4. customthe residue was purified by silica gel column chromatography (hexane/ethyl acetate, 4/1

출처 및 근거

ORD 기록
ord-ca21e0a3ae64460a82af848b7d7c58ea
출처 데이터셋
uspto-grants-2016_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09309276B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트